Travel Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Travel Vaccines Market is Segmented by Type (Cholera, Diptheria Pertussis Tetanus (DPT), Encephalitis, Hepatitis A, Meningococcal, Rabies, Typhoid, Yellow Fever, and Other Types), Travel Type (Domestic and Outbound), Vaccination Center (Hospitals, Travel Clinics, and Other Vaccination Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers Market Sizes and Forecasts in Terms of Value (USD) for all the Above Segments.

Travel Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Travel Vaccines Industry Overview

The travel vaccines market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market share and are well known, including Abbott Laboratories, AstraZeneca plc, CSL Ltd, F. Hoffmann-La Roche AG, GSK PLC, Janssen Pharmaceuticals, Pfizer Inc, Qiagen NV, Sanofi SA, and Valneva SE.

Travel Vaccines Market Leaders

  1. Abbott Laboratories

  2. AstraZeneca plc

  3. GSK plc

  4. Pfizer Inc

  5. Valneva SE

  6. *Disclaimer: Major Players sorted in no particular order
Travel Vaccines Market Concentration